3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
21
Carcinoma, Non-Small-Cell Lung
20
Melanoma
19
Neoplasms
8
Lung Neoplasms
8
Colorectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
6
Prostatic Neoplasms
6
Neoplasm Metastasis
6
Carcinoma, Transitional Cell
6
Carcinoma, Hepatocellular
6
Stomach Neoplasms
5
Rectal Neoplasms
5
Hodgkin Disease
5
Adenocarcinoma Of Esophagus
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Nasopharyngeal Carcinoma
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Pancreatic Neoplasms
3
Oropharyngeal Neoplasms
3
Multiple Myeloma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Brain Neoplasms
3
Anus Neoplasms
3
Anal Canal Carcinoma
3
Interventions
Nuclear Medicine Department, Hospital
6
Magnetic Resonance Spectroscopy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Biopsy
5
Temozolomide
4
Irinotecan
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
dinutuximab
2
Cyclophosphamide
2
trametinib
1
tazemetostat
1
talazoparib
1
saponin QA-21V1
1
palbociclib
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
dabrafenib
1
Vincristine
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Nivolumab
×
30 days
×
Clear all
No trials found.